Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...

Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding ...

Two months of “residential surveillance” have now been turned into an official arrest for Fangliang “Frank” Zhang, the founder of Chinese CDMO giant Genscript Biotech and its CAR-T subsidiary Legend ...

GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

Hong Kong biotech GenScript has had a turbulent 48 hours, with its shares plummeting yesterday on allegations of data falsification in a CAR-T program, only to rebound after it strongly denied the ...